stocksBROOKS
BROOKS

Brooks Laboratories Ltd.

68.53-1.5 (-2.10%)
17 Jul, 12:00 AM

Annual Reports and Financial Documents

Brooks Laboratories Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Brooks Laboratories Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Change in Management17 Jul 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Appointment of Mr. Rajesh Mahajan as President - Trading.
  • Memorandum of Understanding /Agreements16 Jul 2026
    Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
    We hereby inform that, further to the disclosure made by the Company on 19th June 2026 regarding proposed sale of a portion of its shareholding in Brooks Steriscience Limited.
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20189 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of SEBI (DP) Regulation, 2018 for quarter ended 30th June 2026.
  • General2 Jul 2026
    Announcement Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Incorporation Of Wholly Owned Subsidiary.
    Intimation of Incorporation of Wholly Owned Subsidiary.
  • Closure of Trading Window23 Jun 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window.
  • General20 Jun 2026
    Submission Of Additional Details Sought For Corporate Announcement Submitted Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
    With reference to corporate announcement titled "Partial Sale of Equity Shares held in Brooks Steriscience Limited" submitted by the Company on 19th June 2026, we wish to inform you that ....
  • General19 Jun 2026
    Partial Sale Of Equity Shares Held In Brooks Steriscience Limited
    We hereby inform that the Company at its board meeting held today i.e 19th June 2026 has approved sale of 51,220 equity shares held by the Company in Brooks Steriscience Limited to Steriscience ....
  • Newspaper Publication30 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication dated 30th May 2026 of Audited Financial Results for the quarter and year ended 31st March 2026.
  • Reg.24(A)-Annual Secretarial Compliance29 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance Report of the financial year ended 31st March 2026
  • Change in Management29 May 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Appointment of Chief Executive Officer.
  • Outcome of Board Meeting29 May 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, 29Th May 2026
    Outcome of Board Meeting held on Held On Friday, 29th May 2026.
  • Board Meeting22 May 2026
    Board Meeting Intimation for Under Regulation 29 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations'')
    Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve and take on record the ....
  • General14 May 2026
    Update On Scheme Of Arrangement Involving Brooks Steriscience Limited ('BSL'), A Joint Venture / Associate Of The Company.
    Update on Scheme of Arrangement involving Brooks Steriscience Limited ("BSL"), a Joint Venture / Associate of the Company.
  • Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A29 Apr 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201810 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of SEBI(DP) Regulation, 2018 for quarter ended 31st March 2026.
  • General2 Apr 2026
    Reply To Clarification Sought Vide Email Dated 1St April 2026 With Reference To Price Movement.
    Reply to clarification sought vide email dated 1st April 2026 with reference to Price Movement.
  • Closure of Trading Window25 Mar 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window.
  • Newspaper Publication13 Mar 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication regarding the Special Window open for re-lodgement of transfer deed.
  • General6 Mar 2026
    Update On Scheme Of Arrangement Involving Brooks Steriscience Limited ('BSL'), A Joint Venture / Associate Of The Company.
    We refer to our intimation dated September 26, 2025 regarding update on Scheme of Arrangement involving Brooks Steriscience Limited ("BSL"), a Joint Venture/Associate of the Company.
  • Newspaper Publication7 Feb 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication dated 7th February 2026 of the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2025.

Frequently Asked Questions

Where can I download the annual report of Brooks Laboratories Ltd.?
Annual reports of Brooks Laboratories Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Brooks Laboratories Ltd.?
Quarterly earnings results and presentations of Brooks Laboratories Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Brooks Laboratories Ltd. publish earnings call transcripts?
Earnings call transcripts of Brooks Laboratories Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Brooks Laboratories Ltd.?
Investor presentations and annual day presentations of Brooks Laboratories Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Brooks Laboratories Ltd.?
Corporate announcements and regulatory filings of Brooks Laboratories Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Brooks Laboratories Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Brooks Laboratories Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Brooks Laboratories Ltd.?
The ISIN (International Securities Identification Number) of Brooks Laboratories Ltd. is INE650L01011. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Brooks Laboratories Ltd. listed?
Brooks Laboratories Ltd. is listed on NSE and BSE. The NSE symbol is BROOKS and the BSE code is -.
Where can I find the shareholding pattern of Brooks Laboratories Ltd.?
The quarterly shareholding pattern of Brooks Laboratories Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Brooks Laboratories Ltd. on Sharpely?
Share price data for Brooks Laboratories Ltd. is updated as of 17 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.